Technology

Technology

 

Welcome to digital therapy for people with epilepsy

Can you imagine a mobile app which can help to reduce the frequency of seizures in people with epilepsy? Can you imagine that people with epilepsy can reduce seizures by listening to antiseizure music, watching videos and following behavioral therapy delivered via multimedia streaming? Epicadence is developing such technology. To learn more, please read our article in Frontiers in Human Neuroscience.

Mobile Medical App to Reduce the Frequency of Seizures

Epicadence has an exclusive license to the patent-pending digital therapy technology for people with epilepsy. The technology belongs to a category of software as a medical device (SaMD) intended to treat and prevent epileptic seizures. The mobile software created is based on existing clinical evidence on antiseizure effects of audiogenic stimulation with specific musical compositions, as well as psychobehavioral interventions. The mobile software can be combined with streaming antiseizure music, videos, podcast, and self-care content, offering long-term engagement, as well as treatment of epilepsy-associated comorbidities (such as depression and anxiety).

Diverse modalities intended to reduce seizure frequency

Epicadence’s first minimal viable product (MVP) to be developed is the FDA-cleared mobile app operating on iOS and Android platforms that delivers clinically-validated anti-seizure music integrated with epilepsy-specific behavioral therapy. The intended use of the mobile software is as an add-on therapy for adult people with epilepsy. The mobile software device intended for people with epilepsy is currently in the early prototype stage. We anticipate that our MVP development plan will follow the de novo pathway to reach 510(k) clearance from the FDA. Once the MVP receives the regulatory clearance, we will expand our portfolio of digital therapies to pediatric indications, treatment of comorbidities (depression, anxiety) and to multimedia streaming.

Portfolio of Digital Therapeutics for People with Epilepsy